SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2024)
SAB Biotherapeutics' (SABS) quarterly Asset Utilization Ratio came in at 0.03 in Q4 2024, down 32.33% YoY from 0.04 in Q1 2024, and up 3.21% on a QoQ basis from 0.03 in Q3 2024.
SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2024) Analysis & Trends
SAB Biotherapeutics (SABS) has 4 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q4 2024.
- Quarterly Asset Utilization Ratio fell 32.33% year-over-year to 0.03 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.03 (down 32.33% YoY) and the FY2024 annual result came in at 0.02, down 37.84% from the prior year.
- Asset Utilization Ratio grew to 0.03 in Q4 2024, from 0.03 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.75 in Q1 2022 to a low of 0.03 in Q3 2024.
- A 4-year average of 0.29 and a median of 0.16 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 24.79% — and 2023, when it plunged 91.37%.
- Tracing SABS's Asset Utilization Ratio over 4 years: stood at 0.61 in 2021, then dropped by 24.79% to 0.46 in 2022, then sank by 91.37% to 0.04 in 2023, then sank by 32.33% to 0.03 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.03 (Q4 2024), 0.03 (Q3 2024), and 0.04 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | SAB Biotherapeutics | 308.92 Mn | 308.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.59 |
| Jun 30, 2022 | 0.69 |
| Mar 31, 2022 | 0.75 |
| Dec 31, 2021 | 0.61 |